ORLANDO, Fla. - s4story -- sam® Offers a Significant Upgrade in How Soft Tissue, Arthritis and Joint Problems are Managed, Reducing the Reliance on Surgery or Analgesics

The wearable technology enhances recovery by delivering a strong surge of essential elements to the injury location through sustained blood flow to a targeted area for many hours each day. sam® stands out as a secure and reliable method for addressing soft tissue issues, arthritis, and joint discomfort without the typical requirements of surgery or pain relievers. The way this wearable technology works is by boosting the blood supply for several hours daily to a particular zone, thereby administering a concentrated supply of revitalizing elements to the injury site.

Ultrasonic waves emitted by sam® can reach as deep as five centimeters into the tissue. This action enhances the provision of oxygen, nutrients, and overall circulation. Moreover, it encourages the elimination of byproducts, such as lactic acid, from the site of musculoskeletal injuries. Additionally, sam® triggers the tissue renewal process. With these processes combined, the device possesses a distinctive capability to suppress inflammation and tackle the injury's origin, as opposed to just alleviating pain symptoms.

More on S For Story

• Jeekeshen Chinnappen Announces Upcoming Book
• Walmart $WMT and COSTCO.COM $COST Distribution as SonicShieldX™ Platform Sets the Stage for Accelerated Growth in 2026: AXIL Brands (N Y S E: AXIL)
• AI-Driven Drug Development with Publication of New Bioinformatics Whitepaper for BullFrog AI: $BFRG Strengthens Its Position in AI Drug Development
• IQSTEL Enters 2026 from a Position of Strength Following Transformational Year Marked by N A S D A Q Uplisting, Record Revenue and First-Ever
• Are You Hiring The Right Heater Repair Company in Philly?

These factors contribute to why sam® is distinguished as the sole wearable mechanobiological device on the market that is approved by the FDA for continuous usage in treating deep tissue problems in areas like the knees, elbows, back, and neck.
In contrast to typical ultrasound therapies, sam® has been granted FDA approval to provide treatment sessions lasting four hours each day, a significant increase from the standard 20 minutes.

Transcutaneous Electrical Nerve Stimulation (TENS) addresses pain by employing electrical impulses to stimulate nerves, which in turn impedes pain signals from being relayed to the brain. Both TENS and sam® have demonstrated efficacy in clinical research for providing pain relief, however, sam® is unique in its capacity to hasten the body's natural healing mechanisms through mechanical stimulation.

ZetrOZ Systems CEO George Lewis stated, "We engineered sam® with the aim of liberating individuals from the usual constraints of surgery and pain medications when coping with injuries and persistent pain. Even with its high degree of effectiveness, this treatment offers a natural, medication-free pathway to encourage the mending of soft tissue and deliver much-needed comfort from pain, ultimately empowering users to restore their well-being." For more information on ZetrOZ you can call 888-202-9831 (tel:8882029831) or visit here: https://ourseniors.net/services/medical-technology/united-states/connecticut/trumbull/zetroz-systems/

More on S For Story

• Appliance EMT Expands Professional Appliance Repair Services to Hartford, Connecticut
• Java Holdings LLC Acquires +Peptide, Expanding Portfolio Across Coffee, Science, and Functional Nutrition
• First Audiobook Wins Outstanding Creator Awards For Historical Fiction & Other Categories
• Author Michelle Carey Releases Free Fiction and Non-Fiction eBooks to Spark Creative Growth
• OneSolution® Expands to Orlando with New Altamonte Springs Implant Center